Regulus Therapeutics Inc Lands $20,000,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c94f2ff1-bcdb-461f-af61-eb2255003d0d&Preview=1 -
Date
3/4/2009 -
Company Name
Regulus Therapeutics Inc -
Mailing Address
1896 Rutherford Road Carlsbad, CA 92008-7208 -
Company Description
Regulus Therapeutics, Inc., is a biopharmaceutical company created to discover, develop and commercialize microRNA-targeted therapeutics. microRNAs are small non-coding RNAs that regulate networks of genes and biological pathways through post-transcriptional mechanisms. microRNAs function by modulating levels of many target gene mRNAs and/or proteins. Modulation of mRNA targets by microRNAs finely tunes biological pathway activities and deregulated microRNA expression can profoundly affect disease pathways. -
Website
http://www.regulusrx.com -
Transaction Type
Venture Equity -
Transaction Amount
$20,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Alnylam Pharmaceuticals -
Venture Investor
Isis Pharmaceuticals, Inc
